FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2178680271> ?p ?o ?g. }

• W2178680271 abstract "Single-incision laparoscopic surgery (SILS) is an emerging minimally invasive surgery to reduce abdominal incisions. However, despite the increasing clinical application of SILS, no evidence from large-scale, randomized controlled trials is available for assessing the feasibility, short-term safety, oncological safety, and potential benefits of SILS compared with conventional laparoscopic surgery (CLS) for colorectal cancer.This is a single-center, open-label, noninferiority, randomized controlled trial. A total of 198 eligible patients will be randomly assigned to transumbilical single incision plus one port laparoscopic surgery (SILS plus one) group or to a CLS group at a 1:1 ratio. Patients ranging in age from 18 to 80 years with rectosigmoid cancer diagnosed as cT1-4aN0-2 M0 and a tumor size no larger than 5 cm are considered eligible. The primary endpoint is early morbidity, as evaluated by an independent investigator. Secondary outcomes include operative outcomes (operative time, estimated blood loss, and incision length), pathologic outcomes (tumor size, length of proximal and distal resection margins, and number of harvested lymph nodes), postoperative inflammatory and immune responses (white blood cells [WBC], neutrophil percentage [NE %], C-reactive protein [CRP], interleukin-6 [IL-6], and tumor necrosis factor-α [TNF-α]), postoperative recovery (time to first ambulation, flatus, liquid diet, soft diet, and duration of hospital stay), pain intensity, body image and cosmetic assessment, 3-year disease free survival (DFS), and 5-year overall survival (OS). Follow-up visits are scheduled for 1 and 3 months after surgery, then every 3 months for the first 2 years and every 6 months for the next 3 years.This trial will provide valuable clinical evidence for the objective assessment of the feasibility, safety, and potential benefits of SILS plus one compared with CLS for the radical resection of rectosigmoid cancer. The hypothesis is that SILS plus one is feasible for the radical resection of rectosigmoid cancer and offers short-term safety and long-term oncological safety comparable to that of CLS, and that SILS plus one offers better cosmetic results and faster convalescence compared to CLS.ClinicalTrials.gov: NCT02117557 (registered on 16 April 2014)." @default.
• W2178680271 created "2016-06-24" @default.
• W2178680271 creator A5000185840 @default.
• W2178680271 creator A5001681060 @default.
• W2178680271 creator A5019557022 @default.
• W2178680271 creator A5024164106 @default.
• W2178680271 creator A5038339911 @default.
• W2178680271 creator A5042533031 @default.
• W2178680271 creator A5065701013 @default.
• W2178680271 creator A5068242405 @default.
• W2178680271 creator A5069296325 @default.
• W2178680271 creator A5087891437 @default.
• W2178680271 creator A5088664989 @default.
• W2178680271 date "2015-11-30" @default.
• W2178680271 modified "2023-10-15" @default.
• W2178680271 title "A safety study of transumbilical single incision versus conventional laparoscopic surgery for colorectal cancer: study protocol for a randomized controlled trial" @default.
• W2178680271 cites W1558579679 @default.
• W2178680271 cites W1702514783 @default.
• W2178680271 cites W1908682675 @default.
• W2178680271 cites W1969728666 @default.
• W2178680271 cites W1986518474 @default.
• W2178680271 cites W2003717476 @default.
• W2178680271 cites W2006168482 @default.
• W2178680271 cites W2011375064 @default.
• W2178680271 cites W2012168995 @default.
• W2178680271 cites W2026721883 @default.
• W2178680271 cites W2028574636 @default.
• W2178680271 cites W2034260435 @default.
• W2178680271 cites W2035483242 @default.
• W2178680271 cites W2049625051 @default.
• W2178680271 cites W2052139208 @default.
• W2178680271 cites W2053429258 @default.
• W2178680271 cites W2061076542 @default.
• W2178680271 cites W2074254278 @default.
• W2178680271 cites W2076553871 @default.
• W2178680271 cites W2077188080 @default.
• W2178680271 cites W2081408634 @default.
• W2178680271 cites W2086950993 @default.
• W2178680271 cites W2092532974 @default.
• W2178680271 cites W2096998881 @default.
• W2178680271 cites W2108261352 @default.
• W2178680271 cites W2117798960 @default.
• W2178680271 cites W2133061454 @default.
• W2178680271 cites W2134120248 @default.
• W2178680271 cites W2137494450 @default.
• W2178680271 cites W2138000675 @default.
• W2178680271 cites W2139094974 @default.
• W2178680271 cites W2141584579 @default.
• W2178680271 cites W2144695141 @default.
• W2178680271 cites W2167571044 @default.
• W2178680271 cites W2185791496 @default.
• W2178680271 cites W2328892545 @default.
• W2178680271 cites W2515089743 @default.
• W2178680271 cites W2917837889 @default.
• W2178680271 cites W2993539218 @default.
• W2178680271 cites W4292528167 @default.
• W2178680271 cites W4300774608 @default.
• W2178680271 doi "https://doi.org/10.1186/s13063-015-1067-5" @default.
• W2178680271 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4663734" @default.
• W2178680271 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26620555" @default.
• W2178680271 hasPublicationYear "2015" @default.
• W2178680271 type Work @default.
• W2178680271 sameAs 2178680271 @default.
• W2178680271 citedByCount "12" @default.
• W2178680271 countsByYear W21786802712016 @default.
• W2178680271 countsByYear W21786802712017 @default.
• W2178680271 countsByYear W21786802712018 @default.
• W2178680271 countsByYear W21786802712022 @default.
• W2178680271 countsByYear W21786802712023 @default.
• W2178680271 crossrefType "journal-article" @default.
• W2178680271 hasAuthorship W2178680271A5000185840 @default.
• W2178680271 hasAuthorship W2178680271A5001681060 @default.
• W2178680271 hasAuthorship W2178680271A5019557022 @default.
• W2178680271 hasAuthorship W2178680271A5024164106 @default.
• W2178680271 hasAuthorship W2178680271A5038339911 @default.
• W2178680271 hasAuthorship W2178680271A5042533031 @default.
• W2178680271 hasAuthorship W2178680271A5065701013 @default.
• W2178680271 hasAuthorship W2178680271A5068242405 @default.
• W2178680271 hasAuthorship W2178680271A5069296325 @default.
• W2178680271 hasAuthorship W2178680271A5087891437 @default.
• W2178680271 hasAuthorship W2178680271A5088664989 @default.
• W2178680271 hasBestOaLocation W21786802711 @default.
• W2178680271 hasConcept C121608353 @default.
• W2178680271 hasConcept C126322002 @default.
• W2178680271 hasConcept C141071460 @default.
• W2178680271 hasConcept C168563851 @default.
• W2178680271 hasConcept C203092338 @default.
• W2178680271 hasConcept C2776111594 @default.
• W2178680271 hasConcept C2780047204 @default.
• W2178680271 hasConcept C2780120127 @default.
• W2178680271 hasConcept C526805850 @default.
• W2178680271 hasConcept C535046627 @default.
• W2178680271 hasConcept C71924100 @default.
• W2178680271 hasConceptScore W2178680271C121608353 @default.
• W2178680271 hasConceptScore W2178680271C126322002 @default.
• W2178680271 hasConceptScore W2178680271C141071460 @default.
• W2178680271 hasConceptScore W2178680271C168563851 @default.
• W2178680271 hasConceptScore W2178680271C203092338 @default.
• W2178680271 hasConceptScore W2178680271C2776111594 @default.
• W2178680271 hasConceptScore W2178680271C2780047204 @default.

• next